DATROWAY Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival as First-Line Therapy for Patients with Metastatic Triple Negative Breast Cancer for Whom Immunotherapy Was Not an Option in TROPION-Breast02
Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only therapy to…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
IQ Option Joins Forces With United Autosports – Racing Partner Of McLaren Automotive
ST. JOHN'S, Antigua and Barbuda, Sept. 11, 2025 /PRNewswire/ -- IQ Option,…
ASUS Brings 32GB RAM Option Within Everyones Reach with Exclusive Vivobook S16 Starting at C$799.99
KEY POINTS 32GB RAM for all: ASUS makes 32GB memory accessible to…
Mesoblast Enters Into Option To Issue US$50 Million Convertible Notes
September 03, 2025 21:47 ET | Source: Mesoblast Limited NEW YORK, Sept.…
Calidi Biotherapeutics Announces Closing of $6.9 Million Underwritten Public Offering and Full Exercise of Underwriters Over-Allotment Option
SAN DIEGO, Aug. 21, 2025 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE…
REGISTRATION OF THE COMBINATION OF SHARES OF DIGITALIST GROUP PLC, AND ADJUSTMENT OF THE MAXIMUM NUMBERS OF SHARES AVAILABLE FOR SUBSCRIPTION UNDER THE COMPANYS CONVERTIBLE LOANS AND 2021 STOCK OPTION PROGRAM, AND THE SUBSCRIPTION PRICES
August 16, 2025 04:05 ET | Source: Digitalist Group Oyj REGISTRATION OF…
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 16:55 ET | Source: Xenon Pharmaceuticals Inc. VANCOUVER, British…
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
August 01, 2025 17:06 ET | Source: Taysha Gene Therapies, Inc. DALLAS,…
Rakovina Therapeutics Announces Stock Option Grants
July 29, 2025 17:00 ET | Source: Rakovina Therapeutics Inc VANCOUVER, British…